Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Prevention |
RCV000247772 | SCV000313137 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Laboratory for Molecular Medicine, |
RCV000247772 | SCV000538354 | benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency |
Labcorp Genetics |
RCV001520448 | SCV001729542 | benign | Primary ciliary dyskinesia 23 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV001520448 | SCV001775272 | benign | Primary ciliary dyskinesia 23 | 2021-07-14 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001668558 | SCV001887113 | benign | not provided | 2018-11-10 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002461051 | SCV002755604 | benign | Primary ciliary dyskinesia | 2016-07-07 | criteria provided, single submitter | clinical testing | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Breakthrough Genomics, |
RCV001668558 | SCV005316438 | benign | not provided | criteria provided, single submitter | not provided |